At least in Europe and the Nordic systems I have experience with, that typically applies to the very expensive novel treatments. There are gene therapies which can cost $2-3 million per patient and those aren't covered by any public healthcare system, AFAIK.
But it's not like there is some kind of upper limit on coverage. If you have cancer, you will get treatment regardless of how much your care has already cost.